Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 20 AUGUST 2025

What Reclassification Of Marijuana Could Mean For Security Clearance Holders

Tully Rinckey
Explore more from Tully Rinckey

If you are a security clearance holder, or looking to obtain one in the near future, you may be aware that reclassification of marijuana (cannabis, weed, pot) from a Schedule I drug to a Schedule III...

United StatesCannabis & Hemp
Anthony J. Kuhn
Anthony J. Kuhn

If you are a security clearance holder, or looking to obtain one in the near future, you may be aware that reclassification of marijuana (cannabis, weed, pot) from a Schedule I drug to a Schedule III drug could be on its way, and wondering what impact it could have on you.

President Donald Trump has indicated that he may consider supporting a move by the U.S. Drug Enforcement Administration to reclassify marijuana as a Schedule III drug in the near future. On his Truth Social platform, President Donald Trump stated in September 2024 that if elected president, he would work with Congress to pass common-sense laws, including safe banking and supporting states' rights to pass marijuana laws.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

"Marijuana" Rescheduling Delayed, Again. What It Could Mean, And What Comes Next

The DEA's marijuana rescheduling hearing has been unexpectedly stayed following a motion to admit a new GAO report examining agency scheduling procedures. With the proceeding on hold and the medical marijuana Schedule III order facing legal challenges in the D.C. Circuit, the cannabis industry's path to federal tax relief through rescheduling has become increasingly uncertain.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.
United StatesCannabis & Hemp
Foley Hoag LLP
Foley Hoag LLP